The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells

BACKGROUND: Despite progress achieved in bladder cancer (BC) treatment, the prognosis of patients with advanced BC (ie, metastasized from the bladder to other organs) is poor. Although mortality in cases of low-grade BC is rare, the treatment, such as a radical cystectomy, often has a serious impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hong-qing, Liu, Ming-sheng, Deng, Ti-bin, Xie, Ping-bo, Wang, Wei, Shao, Tao, Wu, Yao, Zhang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765330/
https://www.ncbi.nlm.nih.gov/pubmed/31576139
http://dx.doi.org/10.2147/OTT.S212596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765330/
https://www.ncbi.nlm.nih.gov/pubmed/31576139
http://dx.doi.org/10.2147/OTT.S212596

Ejemplares similares